PubMed · 2014 · 34 citations · 9 references
MedicinePharmacologyPharmacotherapyRenal PathophysiologyRenal PharmacotherapyUrolithiasisGoutPharmacologic Management Of GoutRenal DiseaseUrinary ExcretionCrystal NephropathyGout AssociationsMonosodium Urate Crystal DepositionUrate CrystallizationUrate DepositionUrate NephrolithiasisUrologic Complications
Elevated uric acid levels can cause crystal deposition and may lead to gout, urolithiasis, and urate nephropathy. The authors report on the case of a 34-year-old male whose hyperuricemia was associated with the antituberculous drug pyrazinamide.
9
A method for estimating the probability of adverse drug reactions
C. A. Naranjo, U. Busto, Edward M. Sellers et al. · Clinical Pharmacology & Therapeutics · 1981 · 11.6K citations
Mark D. Harris, Louis Siegel, J A Alloway · PubMed · 1999 · 185 citations
Rasburicase for tophaceous gout not treatable with allopurinol: an exploratory study.
Pascal Richette, Claire Brière, V. Hoenen-Clavert et al. · PubMed · 2007 · 89 citations
Alexander B. Gutma, Ts’ai-Fan Yű, Lawrence R. Berger · The American Journal of Medicine · 1969 · 74 citations
Medicine, Nephrology, Physiology +10